SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-017038
Filing Date
2023-05-15
Accepted
2023-05-15 11:05:44
Documents
19
Period of Report
2023-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54314
2 ex4-1.htm EX-4.1 108934
3 ex4-2.htm EX-4.2 111849
4 ex4-3.htm EX-4.3 111834
5 ex4-4.htm EX-4.4 119290
6 ex10-1.htm EX-10.1 248897
7 ex99-1.htm EX-99.1 15628
8 ex99-1_001.jpg GRAPHIC 4264
  Complete submission text file 0001493152-23-017038.txt   1114323

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ensc-20230515.xsd EX-101.SCH 3224
10 XBRL LABEL FILE ensc-20230515_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE ensc-20230515_pre.xml EX-101.PRE 22357
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3731
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 23919640
SIC: 2834 Pharmaceutical Preparations